113

Business

Novozymes named 2012 Transatlantic Company of the Year

admin
March 28th, 2012


This article is more than 12 years old.

American Chamber honours biotech company for its alliances and investments in the US

Danish biotech company Novozymes has been recognised as the Transatlantic Company of the Year by the American Chamber of Commerce in Denmark.

“They have won this year’s prize due to its strong alliances based on innovation as well as its substantial investments in the US,” jury member Sten Scheibye, chairman of the Danish Trade Council, explained. He added that Novozymes is exceptionally well integrated in American industry. “They have partnerships with major US corporations such as Procter & Gamble and POET, which is the world’s largest producer of biofuel. These strong strategic alliances are based on continuous product development and innovation.”

 

AmCham Denmark’s Transatlantic Company of the Year is awarded to an AmCham member company with business interests in the US that has demonstrated significant achievements in several areas, like investments in the US or strategic partnerships.

 

Novozymes president and chief executive Steen Riisgaard was grateful for the prize, noting that Novozymes is the world leader in the development and production of industrial enzymes. 

 

“We’ve had sales in the US for many years, and in the late ‘70s, we established production and research in North Carolina,” Riisgaard told The Copenhagen Post. “Today we have operations in several states with about one thousand employees in North America, and soon we will open a new enzyme plant in Blair, Nebraska. North America means a lot to us, and, of course, it is nice to get recognition for our success.”

 

AmCham’s executive director, Stephen Brugger, added that it’s important to remain focused on improving the transatlantic trade. “Although there is considerable focus on the BRIC countries [Brazil, Russia, India and China] these days, it is worth noting that the US and EU together still represent the world’s largest single economic relationship with a value of approximately $5 trillion American dollars,” he said.


Share

Most popular

Subscribe to our newsletter

Sign up to receive The Daily Post

















Latest Podcast

A survey carried out by Megafon for TV2 has found that 71 percent of parents have handed over children to daycare in spite of them being sick.

Moreover, 21 percent of those surveyed admitted to medicating their kids with paracetamol, such as Panodil, before sending them to school.

The FOLA parents’ organisation is shocked by the findings.

“I think it is absolutely crazy. It simply cannot be that a child goes to school sick and plays with lots of other children. Then we are faced with the fact that they will infect the whole institution,” said FOLA chair Signe Nielsen.

Pill pushers
At the Børnehuset daycare institution in Silkeborg a meeting was called where parents were implored not to bring their sick children to school.

At Børnehuset there are fears that parents prefer to pack their kids off with a pill without informing teachers.

“We occasionally have children who that they have had a pill for breakfast,” said headteacher Susanne Bødker. “You might think that it is a Panodil more than a vitamin pill, if it is a child who has just been sick, for example.”

Parents sick and tired
Parents, when confronted, often cite pressure at work as a reason for not being able to stay at home with their children.

Many declare that they simply cannot take another day off, as they are afraid of being fired.

Allan Randrup Thomsen, a professor of virology at KU, has heavily criticised the parents’ actions, describing the current situation as a “vicious circle”.

“It promotes the spread of viruses, and it adds momentum to a cycle where parents are pressured by high levels of sick-leave. If they then choose to send the children to daycare while they are still recovering, they keep the epidemic going in daycares, and this in turn puts a greater burden on the parents.”